Share Price and Basic Stock Data
Last Updated: March 9, 2025, 8:27 pm
PEG Ratio | 0.98 |
---|
Competitors of Albert David Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
MPS Pharmaa Ltd | 6.71 Cr. | 3.51 | 4.33/3.05 | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 | |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 53.1 Cr. | 71.5 | 94.9/32.1 | 18.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 38.0 Cr. | 26.0 | 29.0/8.74 | 38.8 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 70.4 Cr. | 93.5 | 155/79.0 | 11.4 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Industry Average | 17,255.37 Cr | 1,081.84 | 42.42 | 185.80 | 0.37% | 16.00% | 16.32% | 6.27 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 71.70 | 74.37 | 93.20 | 92.38 | 74.57 | 81.42 | 91.95 | 93.18 | 88.28 | 89.06 | 89.36 | 98.44 | 83.08 |
Expenses | 64.44 | 64.35 | 80.99 | 78.13 | 66.28 | 71.83 | 78.96 | 77.21 | 79.92 | 79.49 | 88.48 | 92.22 | 82.40 |
Operating Profit | 7.26 | 10.02 | 12.21 | 14.25 | 8.29 | 9.59 | 12.99 | 15.97 | 8.36 | 9.57 | 0.88 | 6.22 | 0.68 |
OPM % | 10.13% | 13.47% | 13.10% | 15.43% | 11.12% | 11.78% | 14.13% | 17.14% | 9.47% | 10.75% | 0.98% | 6.32% | 0.82% |
Other Income | 6.03 | -0.69 | -5.60 | 13.53 | 7.46 | 0.01 | 18.13 | 12.10 | 16.88 | 10.44 | 23.06 | 20.64 | -9.01 |
Interest | 0.10 | 0.17 | 0.11 | 0.13 | 0.11 | 0.11 | 0.08 | 0.06 | 0.12 | 0.07 | 0.09 | 0.06 | 0.13 |
Depreciation | 2.31 | 2.39 | 2.12 | 2.07 | 2.06 | 2.30 | 1.85 | 1.46 | 1.68 | 1.83 | 1.79 | 1.67 | 1.70 |
Profit before tax | 10.88 | 6.77 | 4.38 | 25.58 | 13.58 | 7.19 | 29.19 | 26.55 | 23.44 | 18.11 | 22.06 | 25.13 | -10.16 |
Tax % | 26.75% | 38.26% | 59.82% | 21.31% | 22.39% | 48.12% | 19.53% | 23.54% | 20.14% | 28.77% | 14.60% | 28.09% | -7.68% |
Net Profit | 7.97 | 4.17 | 1.76 | 20.14 | 10.55 | 3.73 | 23.49 | 20.30 | 18.72 | 12.91 | 18.84 | 18.07 | -9.39 |
EPS in Rs | 13.96 | 7.31 | 3.08 | 35.29 | 18.49 | 6.54 | 41.16 | 35.57 | 32.80 | 22.62 | 33.01 | 31.66 | -16.45 |
Last Updated: February 28, 2025, 8:42 pm
Below is a detailed analysis of the quarterly data for Albert David Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹83.08 Cr.. The value appears to be declining and may need further review. It has decreased from 98.44 Cr. (Sep 2024) to ₹83.08 Cr., marking a decrease of 15.36 Cr..
- For Expenses, as of Dec 2024, the value is ₹82.40 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 92.22 Cr. (Sep 2024) to ₹82.40 Cr., marking a decrease of 9.82 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹0.68 Cr.. The value appears to be declining and may need further review. It has decreased from 6.22 Cr. (Sep 2024) to ₹0.68 Cr., marking a decrease of 5.54 Cr..
- For OPM %, as of Dec 2024, the value is 0.82%. The value appears to be declining and may need further review. It has decreased from 6.32% (Sep 2024) to 0.82%, marking a decrease of 5.50%.
- For Other Income, as of Dec 2024, the value is ₹-9.01 Cr.. The value appears to be declining and may need further review. It has decreased from 20.64 Cr. (Sep 2024) to ₹-9.01 Cr., marking a decrease of 29.65 Cr..
- For Interest, as of Dec 2024, the value is ₹0.13 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Sep 2024) to ₹0.13 Cr., marking an increase of ₹0.07 Cr..
- For Depreciation, as of Dec 2024, the value is ₹1.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.67 Cr. (Sep 2024) to ₹1.70 Cr., marking an increase of ₹0.03 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹-10.16 Cr.. The value appears to be declining and may need further review. It has decreased from 25.13 Cr. (Sep 2024) to ₹-10.16 Cr., marking a decrease of 35.29 Cr..
- For Tax %, as of Dec 2024, the value is -7.68%. The value appears to be improving (decreasing) as expected. It has decreased from 28.09% (Sep 2024) to -7.68%, marking a decrease of 35.77%.
- For Net Profit, as of Dec 2024, the value is ₹-9.39 Cr.. The value appears to be declining and may need further review. It has decreased from 18.07 Cr. (Sep 2024) to ₹-9.39 Cr., marking a decrease of 27.46 Cr..
- For EPS in Rs, as of Dec 2024, the value is -16.45. The value appears to be declining and may need further review. It has decreased from ₹31.66 (Sep 2024) to -16.45, marking a decrease of ₹48.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 9:20 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 261 | 287 | 317 | 318 | 293 | 285 | 316 | 320 | 246 | 313 | 341 | 362 | 360 |
Expenses | 236 | 254 | 281 | 286 | 266 | 267 | 286 | 289 | 227 | 272 | 297 | 315 | 343 |
Operating Profit | 26 | 33 | 37 | 31 | 27 | 18 | 30 | 30 | 19 | 41 | 44 | 47 | 17 |
OPM % | 10% | 11% | 12% | 10% | 9% | 6% | 10% | 10% | 8% | 13% | 13% | 13% | 5% |
Other Income | 2 | 1 | 2 | 43 | 8 | 9 | 15 | 7 | 17 | 16 | 15 | 58 | 45 |
Interest | 4 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Depreciation | 11 | 11 | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 | 7 |
Profit before tax | 13 | 18 | 20 | 63 | 26 | 18 | 38 | 29 | 27 | 47 | 51 | 97 | 55 |
Tax % | 36% | 32% | 32% | 24% | 39% | 45% | 29% | 34% | 19% | 25% | 29% | 22% | |
Net Profit | 9 | 13 | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 75 | 40 |
EPS in Rs | 15.00 | 22.02 | 24.00 | 84.10 | 27.96 | 17.24 | 46.68 | 33.59 | 38.79 | 61.78 | 63.38 | 132.15 | 70.84 |
Dividend Payout % | 30% | 23% | 23% | 7% | 20% | 32% | 13% | 21% | 15% | 15% | 14% | 9% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 44.44% | 7.69% | 242.86% | -66.67% | -37.50% | 170.00% | -29.63% | 15.79% | 59.09% | 2.86% | 108.33% |
Change in YoY Net Profit Growth (%) | 0.00% | -36.75% | 235.16% | -309.52% | 29.17% | 207.50% | -199.63% | 45.42% | 43.30% | -56.23% | 105.48% |
Albert David Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: February 12, 2025, 4:11 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 75 | 85 | 87 | 131 | 177 | 180 | 205 | 217 | 239 | 274 | 306 | 377 | 408 |
Borrowings | 38 | 42 | 30 | 20 | 30 | 28 | 0 | 2 | 2 | 6 | 5 | 3 | 4 |
Other Liabilities | 64 | 66 | 71 | 67 | 71 | 76 | 84 | 95 | 95 | 116 | 106 | 112 | 119 |
Total Liabilities | 183 | 198 | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 535 |
Fixed Assets | 72 | 67 | 49 | 44 | 87 | 83 | 77 | 91 | 84 | 88 | 80 | 83 | 83 |
CWIP | 1 | 3 | 5 | 5 | 9 | 5 | 5 | 2 | 1 | 1 | 3 | 7 | 14 |
Investments | -0 | 16 | 16 | 48 | 59 | 68 | 113 | 122 | 138 | 183 | 193 | 273 | 296 |
Other Assets | 110 | 111 | 122 | 127 | 130 | 134 | 99 | 106 | 119 | 130 | 148 | 135 | 142 |
Total Assets | 183 | 198 | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 535 |
Below is a detailed analysis of the balance sheet data for Albert David Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹6.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹408.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹377.00 Cr. (Mar 2024) to ₹408.00 Cr., marking an increase of 31.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹4.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹3.00 Cr. (Mar 2024) to ₹4.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹119.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹112.00 Cr. (Mar 2024) to ₹119.00 Cr., marking an increase of 7.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹535.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹498.00 Cr. (Mar 2024) to ₹535.00 Cr., marking an increase of 37.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹83.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹14.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹7.00 Cr. (Mar 2024) to ₹14.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Sep 2024, the value is ₹296.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹273.00 Cr. (Mar 2024) to ₹296.00 Cr., marking an increase of 23.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹142.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹135.00 Cr. (Mar 2024) to ₹142.00 Cr., marking an increase of 7.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹535.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹498.00 Cr. (Mar 2024) to ₹535.00 Cr., marking an increase of 37.00 Cr..
Notably, the Reserves (₹408.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
No data available for this post.
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -12.00 | -9.00 | 7.00 | 11.00 | -3.00 | -10.00 | 30.00 | 28.00 | 17.00 | 35.00 | 39.00 | 44.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 52 | 54 | 47 | 41 | 41 | 35 | 25 | 34 | 29 | 29 | 32 | 30 |
Inventory Days | 165 | 191 | 176 | 187 | 217 | 173 | 151 | 148 | 151 | 124 | 149 | 126 |
Days Payable | 110 | 135 | 103 | 102 | 117 | 127 | 102 | 132 | 104 | 96 | 95 | 98 |
Cash Conversion Cycle | 107 | 111 | 120 | 126 | 141 | 81 | 74 | 50 | 76 | 57 | 87 | 58 |
Working Capital Days | 61 | 57 | 52 | 48 | 61 | 45 | 22 | 18 | -8 | -29 | 19 | -10 |
ROCE % | 14% | 18% | 18% | 17% | 15% | 7% | 18% | 14% | 12% | 17% | 17% | 28% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 |
Diluted EPS (Rs.) | 132.15 | 63.39 | 61.78 | 38.80 | 33.59 |
Cash EPS (Rs.) | 144.11 | 78.36 | 77.21 | 53.22 | 47.03 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 671.05 | 545.93 | 489.68 | 428.20 | 390.38 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 671.05 | 545.93 | 489.68 | 428.20 | 390.38 |
Dividend / Share (Rs.) | 11.50 | 9.00 | 9.00 | 6.00 | 7.00 |
Revenue From Operations / Share (Rs.) | 635.10 | 598.48 | 549.33 | 433.57 | 562.09 |
PBDIT / Share (Rs.) | 182.98 | 104.67 | 99.23 | 63.65 | 65.58 |
PBIT / Share (Rs.) | 171.02 | 89.69 | 83.81 | 49.23 | 52.13 |
PBT / Share (Rs.) | 170.46 | 88.90 | 82.87 | 48.09 | 50.73 |
Net Profit / Share (Rs.) | 132.15 | 63.38 | 61.78 | 38.80 | 33.59 |
PBDIT Margin (%) | 28.81 | 17.49 | 18.06 | 14.68 | 11.66 |
PBIT Margin (%) | 26.92 | 14.98 | 15.25 | 11.35 | 9.27 |
PBT Margin (%) | 26.84 | 14.85 | 15.08 | 11.09 | 9.02 |
Net Profit Margin (%) | 20.80 | 10.59 | 11.24 | 8.94 | 5.97 |
Return on Networth / Equity (%) | 19.69 | 11.61 | 12.61 | 9.06 | 8.60 |
Return on Capital Employeed (%) | 24.46 | 15.77 | 16.27 | 10.77 | 12.43 |
Return On Assets (%) | 15.14 | 8.54 | 8.75 | 6.48 | 5.98 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
Asset Turnover Ratio (%) | 0.78 | 0.82 | 0.84 | 0.74 | 1.04 |
Current Ratio (X) | 3.75 | 3.07 | 2.33 | 2.77 | 2.48 |
Quick Ratio (X) | 3.31 | 2.55 | 1.97 | 2.33 | 1.95 |
Inventory Turnover Ratio (X) | 1.36 | 1.41 | 1.37 | 0.93 | 1.29 |
Dividend Payout Ratio (NP) (%) | 6.81 | 14.19 | 9.71 | 0.00 | 46.66 |
Dividend Payout Ratio (CP) (%) | 6.24 | 11.48 | 7.77 | 0.00 | 33.32 |
Earning Retention Ratio (%) | 93.19 | 85.81 | 90.29 | 0.00 | 53.34 |
Cash Earning Retention Ratio (%) | 93.76 | 88.52 | 92.23 | 0.00 | 66.68 |
Interest Coverage Ratio (X) | 325.13 | 131.04 | 106.40 | 55.62 | 47.01 |
Interest Coverage Ratio (Post Tax) (X) | 235.81 | 80.35 | 67.24 | 34.90 | 25.08 |
Enterprise Value (Cr.) | 584.89 | 270.90 | 288.62 | 180.08 | 178.32 |
EV / Net Operating Revenue (X) | 1.61 | 0.79 | 0.92 | 0.72 | 0.55 |
EV / EBITDA (X) | 5.60 | 4.53 | 5.10 | 4.96 | 4.76 |
MarketCap / Net Operating Revenue (X) | 1.69 | 0.85 | 0.96 | 0.86 | 0.57 |
Retention Ratios (%) | 93.18 | 85.80 | 90.28 | 0.00 | 53.33 |
Price / BV (X) | 1.60 | 0.93 | 1.09 | 0.87 | 0.82 |
Price / Net Operating Revenue (X) | 1.69 | 0.85 | 0.96 | 0.86 | 0.57 |
EarningsYield | 0.12 | 0.12 | 0.11 | 0.10 | 0.10 |
After reviewing the key financial ratios for Albert David Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.39 (Mar 23) to 132.15, marking an increase of 68.76.
- For Diluted EPS (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.39 (Mar 23) to 132.15, marking an increase of 68.76.
- For Cash EPS (Rs.), as of Mar 24, the value is 144.11. This value is within the healthy range. It has increased from 78.36 (Mar 23) to 144.11, marking an increase of 65.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 671.05. It has increased from 545.93 (Mar 23) to 671.05, marking an increase of 125.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 671.05. It has increased from 545.93 (Mar 23) to 671.05, marking an increase of 125.12.
- For Dividend / Share (Rs.), as of Mar 24, the value is 11.50. This value exceeds the healthy maximum of 3. It has increased from 9.00 (Mar 23) to 11.50, marking an increase of 2.50.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 635.10. It has increased from 598.48 (Mar 23) to 635.10, marking an increase of 36.62.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 182.98. This value is within the healthy range. It has increased from 104.67 (Mar 23) to 182.98, marking an increase of 78.31.
- For PBIT / Share (Rs.), as of Mar 24, the value is 171.02. This value is within the healthy range. It has increased from 89.69 (Mar 23) to 171.02, marking an increase of 81.33.
- For PBT / Share (Rs.), as of Mar 24, the value is 170.46. This value is within the healthy range. It has increased from 88.90 (Mar 23) to 170.46, marking an increase of 81.56.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 132.15. This value is within the healthy range. It has increased from 63.38 (Mar 23) to 132.15, marking an increase of 68.77.
- For PBDIT Margin (%), as of Mar 24, the value is 28.81. This value is within the healthy range. It has increased from 17.49 (Mar 23) to 28.81, marking an increase of 11.32.
- For PBIT Margin (%), as of Mar 24, the value is 26.92. This value exceeds the healthy maximum of 20. It has increased from 14.98 (Mar 23) to 26.92, marking an increase of 11.94.
- For PBT Margin (%), as of Mar 24, the value is 26.84. This value is within the healthy range. It has increased from 14.85 (Mar 23) to 26.84, marking an increase of 11.99.
- For Net Profit Margin (%), as of Mar 24, the value is 20.80. This value exceeds the healthy maximum of 10. It has increased from 10.59 (Mar 23) to 20.80, marking an increase of 10.21.
- For Return on Networth / Equity (%), as of Mar 24, the value is 19.69. This value is within the healthy range. It has increased from 11.61 (Mar 23) to 19.69, marking an increase of 8.08.
- For Return on Capital Employeed (%), as of Mar 24, the value is 24.46. This value is within the healthy range. It has increased from 15.77 (Mar 23) to 24.46, marking an increase of 8.69.
- For Return On Assets (%), as of Mar 24, the value is 15.14. This value is within the healthy range. It has increased from 8.54 (Mar 23) to 15.14, marking an increase of 6.60.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.78. It has decreased from 0.82 (Mar 23) to 0.78, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 24, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 3.07 (Mar 23) to 3.75, marking an increase of 0.68.
- For Quick Ratio (X), as of Mar 24, the value is 3.31. This value exceeds the healthy maximum of 2. It has increased from 2.55 (Mar 23) to 3.31, marking an increase of 0.76.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.36. This value is below the healthy minimum of 4. It has decreased from 1.41 (Mar 23) to 1.36, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.81. This value is below the healthy minimum of 20. It has decreased from 14.19 (Mar 23) to 6.81, marking a decrease of 7.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.24. This value is below the healthy minimum of 20. It has decreased from 11.48 (Mar 23) to 6.24, marking a decrease of 5.24.
- For Earning Retention Ratio (%), as of Mar 24, the value is 93.19. This value exceeds the healthy maximum of 70. It has increased from 85.81 (Mar 23) to 93.19, marking an increase of 7.38.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.76. This value exceeds the healthy maximum of 70. It has increased from 88.52 (Mar 23) to 93.76, marking an increase of 5.24.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 325.13. This value is within the healthy range. It has increased from 131.04 (Mar 23) to 325.13, marking an increase of 194.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 235.81. This value is within the healthy range. It has increased from 80.35 (Mar 23) to 235.81, marking an increase of 155.46.
- For Enterprise Value (Cr.), as of Mar 24, the value is 584.89. It has increased from 270.90 (Mar 23) to 584.89, marking an increase of 313.99.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has increased from 0.79 (Mar 23) to 1.61, marking an increase of 0.82.
- For EV / EBITDA (X), as of Mar 24, the value is 5.60. This value is within the healthy range. It has increased from 4.53 (Mar 23) to 5.60, marking an increase of 1.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 0.85 (Mar 23) to 1.69, marking an increase of 0.84.
- For Retention Ratios (%), as of Mar 24, the value is 93.18. This value exceeds the healthy maximum of 70. It has increased from 85.80 (Mar 23) to 93.18, marking an increase of 7.38.
- For Price / BV (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 0.93 (Mar 23) to 1.60, marking an increase of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 0.85 (Mar 23) to 1.69, marking an increase of 0.84.
- For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Albert David Ltd:
- Net Profit Margin: 20.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.46% (Industry Average ROCE: 16%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.69% (Industry Average ROE: 16.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 235.81
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.31
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.6 (Industry average Stock P/E: 42.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.8%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Pharmaceuticals | D - Block, 3rd Floor, Gillander House, Kolkata West Bengal 700001 | adidavid@dataone.in http://www.albertdavidindia.com |
Management | |
---|---|
Name | Position Held |
Mr. Arun Kumar Kothari | Executive Chairman |
Mr. Umesh Manohar Kunte | Managing Director & CEO |
Mrs. Prabhawati Devi Kothari | Non Executive Director |
Mr. Anand Vardhan Kothari | Non Executive Director |
Mr. Anurag Singhi | Ind. Non-Executive Director |
Mr. Shourya Sengupta | Ind. Non-Executive Director |
Mr. Shirish G Belapure | Ind. Non-Executive Director |
Dr. Monjori Mitra | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of Albert David Ltd?
The latest intrinsic value of Albert David Ltd as on 12 March 2025 is ₹1604.08, which is 79.63% higher than the current market price of 893.00, indicating the stock is undervalued by 79.63%. The intrinsic value of Albert David Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹510 Cr. and recorded a high/low of ₹1,754/810 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹408 Cr and total liabilities of ₹535 Cr.
What is the Market Cap of Albert David Ltd?
The Market Cap of Albert David Ltd is 510 Cr..
What is the current Stock Price of Albert David Ltd as on 12 March 2025?
The current stock price of Albert David Ltd as on 12 March 2025 is ₹893.
What is the High / Low of Albert David Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Albert David Ltd stocks is ₹1,754/810.
What is the Stock P/E of Albert David Ltd?
The Stock P/E of Albert David Ltd is 12.6.
What is the Book Value of Albert David Ltd?
The Book Value of Albert David Ltd is 724.
What is the Dividend Yield of Albert David Ltd?
The Dividend Yield of Albert David Ltd is 1.29 %.
What is the ROCE of Albert David Ltd?
The ROCE of Albert David Ltd is 27.8 %.
What is the ROE of Albert David Ltd?
The ROE of Albert David Ltd is 21.7 %.
What is the Face Value of Albert David Ltd?
The Face Value of Albert David Ltd is 10.0.